Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034727 | PMC |
http://dx.doi.org/10.1590/0100-3984.2016.0159 | DOI Listing |
Urol Case Rep
November 2024
Florida State University College of Medicine, 1115 W Call St, Tallahassee, FL, 32304, USA.
A primary seminal vesicle leiomyoma (PSVL) is a rare male genitourinary tract tumor. No previous reports have utilized a robotic-assisted laparoscopic posterior approach (RALPA) for surgical management. A 76-year-old man was incidentally found to have a 5cm lobulated mass posterior to the bladder in an abdominal/pelvic computed tomography scan.
View Article and Find Full Text PDFJ Surg Case Rep
March 2024
Department of Urology, University of Iowa, Iowa City, IA 52242, USA.
Leiomyosarcoma of the prostate is a rare and aggressive tumor, with a quarter of the patients harboring metastatic disease, commonly in the lung. It usually presents with urinary obstruction in a relatively younger patient group. A 29-year-old male presented with lower urinary tract symptoms to the urologist.
View Article and Find Full Text PDFBMC Urol
January 2022
Department of Pathology, Binzhou Medical University Hospital, Binzhou, 256603, Shandong Province, China.
Background: Leiomyoma of the seminal vesicle is a rare leiomyoma characterized by the formation of benign leiomyomatous tissue within the seminal vesicle. Although histologically benign, excessive size can lead to urinary system disease if left untreated. Herein, we report a case of a seminal vesicle epithelioid leiomyoma.
View Article and Find Full Text PDFRadiographics
March 2022
From the Department of Abdominal Imaging, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1473, Houston, TX 77030-4009 (L.P.M., V.R.S., S.R.P.); Department of Pathology, Michael E. DeBakey VA Medical Center, Houston, Tex (N.S.R.); Department of Radiology, University of Texas Health Science Center, San Antonio, Tex (V.S.K.); and Department of Radiology, Case Western Reserve University, Cleveland, Ohio (R.M.P.).
There is a wide spectrum of benign and malignant mesenchymal neoplasms of the prostate, which account for less than 1% of all prostatic tumors. These include distinctive tumors that arise from the specialized prostatic stroma and site-agnostic neoplasms such as smooth muscle tumors, fibrous or myofibroblastic neoplasms, neurogenic tumors, vascular tumors, and a plethora of sarcomas. Select tumors show classic sites of origin within the prostate.
View Article and Find Full Text PDFUrology
January 2022
Department of Radiology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, P.R. China. Electronic address:
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!